Protective effects of alpha-lipoic acid against oxidative injury in TNBS-induced colitis

Erciyes Tip Dergisi

Volumn 31, Issue 1, 2009, Pages 015-026

  Şehirli, Ahmet Özer ^a   Tatlidede, Elif ^a   Yüksel, Meral ^a   Çetinel, Şule ^a   Erzik, Can ^a   Yeǧen, Berrak ^a   Şener, Göksel ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Alpha lipoic acid; Colitis; Cytokines; Glutathione; Tumor necrosis factor alpha

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); COLLAGEN; GLUTATHIONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LUCIGENIN; LUMINOL; MALONALDEHYDE; MYELOPEROXIDASE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA FRAGMENTATION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SPRAGUE DAWLEY RAT;

EID: 69949095158     PISSN: 1300199X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Woodruff TM, Arumugam TV, et al. A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis. Int Immunopharmacol 2005; 5: 883-892.
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347: 417-429.
3. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521-533.
4. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004; 126: 1620.1633.
5. Maeda S, Hsu LC, Liu H, et al. Nod2 mutation in Crohn's disease potentiates NF-êB activity and IL-1â processing. Science 2005; 307: 734-738.
6. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunit. 2002; 17: 629-638.
7. Uhlig HH, Powrie F. Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responses. J Clin Invest 2003; 112: 648-651.
8. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998; 115: 182-205.
9. Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003; 201: 28-36.
10. Murata Y, Ishiguro Y, Itoh J, Munakata A, Yoshida Y. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gastroenterol; 1995; 30: 56-60.
11. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg 1998; 22: 382-389.
12. Yoshida N, Yoshikawa T, Yamaguchi T, et al. A novel water-soluble vitamin E derivative protects against experimental colitis in rats. Antioxid Redox Signal 1999; 1: 555-562.
13. Gulluoglu BM, Kurtel H, Gulluoglu MG, et al. Role of endothelins in trinitrobenzene sulfonic acid-induced colitis in rats. Digestion 1999; 60: 484-492.
14. Ukil A, Maity S, Karmakar S, Datta N, Vedasiromoni JR, Das PK. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br J Pharmacol 2003; 139: 209-218.
15. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109: 1344-1367.
16. Little JR, Einsen HN. Preparation and characterization of antibodies specific for the 2,4,6-trinitrophenyl group. Biochemistry 1966; 5: 3385-3395.
17. Kunin S, Gallily R. Recognition and lysis of altered-self cells by macrophages. Modification of target cells by 2,4,6-trinitrobenzene sulfonic acid. Immunology 1983; 48: 265-272.
18. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic as biological antioxidant. A review. Free Rad Biol Med 1995; 19: 227-250.
19. Ho YS, Lai CS, Liu HI, et al. Dihydrolipoic acid inhibits skin tumor promotion through anti-inflammation and anti-oxidation. Biochem Pharmacol 2007; 73: 1786-1795.
20. Sener G, Aksoy H, Sehirli O, et al. Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities. Dig Dis Sci 2007; 52: 2122-2132.
21. Martinek RG. A rapid ultraviolent spectrophotomeetric lactic dehydrogenase assay. Clin Chem Acta 1972; 40: 91-99.
22. Beuge JA, Aust SD. Microsomal lipid peroxidation. Meth. Enzymol 1978; 53: 302-11.
23. Beutler E. Glutathione in red blood cell metabolism A manual of biochemical methods. New York: Grune & Stratton, 1975; pp. 112-114.
24. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78:206-209.
25. Hillegass LM, Griswold DE, Brickson B, Albrightsonwinslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Meth 1990; 24: 285-295.
26. Reading HW, Isbir T. The role of cation activated ATPase in transmitter release from the art iris. Q J Exp Physiol 1980; 65: 105-16.
27. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
28. Lopez De Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed parraffin-embedded sections. J Histochem Cytochem 1985; 33: 737-743.
29. Davies GR, Simmonds NJ, Stevens TRJ, Grandison A, Blake DR, Rampton DS. Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 1992; 33: 1467-1472.
30. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-2551.
31. Haklar G, Yüksel M, Yalçin AS. Chemiluminescence in the measurement of free radicals: Theory and application on a tissue injury model. Marmara Medical Journal 1998; 11: 56-60.
32. Wyllie H. Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-556.
33. Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J 1956; 62: 315-323.
34. Packer L, Suzuki YJ. Vitamin-E and alpha-lipoate - role in antioxidant recycling and activation of the NF-kappa-b transcription factor, Mol Aspects Med 1993; 14: 229-239.
35. Suzuki YJ, Tsuchiya M, Packer L. Antioxidant activities of dihydrolipoic acid and its structural homologues. Free Radic Res Commun 1993; 18: 115-122.
36. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160: 1-40.
37. Selvakumar E, Prahalathan C, Sudharsan PT, Varalakshmi P. Protective of lipoic acid on cyclophosphamide-induced testicular toxicity. Clin Chim Acta 2006; 367: 114-119.
38. Prahalathan C, Selvakumar E, Varalakshmi P, Kumarasamy P, Saravanan R. Salubrious effects of lipoic acid against adriamycin-induced clastogenesis and apoptosis in Wistar rat bone marrow cells. Toxicology 2006; 222: 225-232.
39. Javor T, Tarnok F, Past T, Nagy S. Cytoprotective effect of free radical scavengers against mucosal damage produced by different antirheumatic drugs. Int J Tissue React 1986; 8: 35-40.
40. Shanahan F. Pathogenesis of ulcerative colitis. Lancet 1993; 342: 407-411.
41. MacPherson B, Pfeiffer C. Experimental production of diffuse colitis in rats. Digestion 1978; 17: 135-150.
42. Noa M, M'as R, Carbajal D, Vald'es S. Effect of D-002 on acetic acid-induced colitis in rats at single and repeated doses. Pharmacol Res 2000; 41: 391-395.
43. Sharon P, Stenson WF. Metabolism of arachidonic acid in acetic acid colitis in rats. Gastroenterology 1985; 88: 55-63.
44. Peifer C, Wagner G, Laufer S. New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase. Curr Top Med Chem 2006; 6: 113-149.
45. Cuzzocrea S, Mazzon E, Serraino I, et al. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res 2001; 30: 1-12.
46. Adam B, Liebregts T, Gschossmann JM, et al. Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model. Pain 2006; 123: 179-186.
47. Song M, Xia B, Li J. Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats. Postgrad Med J 2006; 82: 130-135.
48. Park SJ, Seo SW, Choi OS, Park CS. Alpha-lipoic acid protects against cholecystokinin-induced acute pancreatitis in rats. World J Gastroenterol 2005; 11: 4883-4885.
49. Dulundu E, Ozel Y, Topaloglu U, et al. Alpha-lipoic acid protects against hepatic ischemia-reperfusion injury in rats. Pharmacology 2007; 79:163-170.
50. Ross D. Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. Pharmacol Ther 1988; 37: 231-249.
51. Necefli A, Tulumoglu B, Giris M, et al. The effect of melatonin on TNBS-induced colitis. Dig Dis Sci 2006; 51: 1538-1545.
52. Jahovic N, Ercan F, Gedik N, Yuksel M, Sener G, Alican I. The effect of angiotensin-converting enzyme inhibitors on experimental colitis in rats. Regul Pept 2005; 130: 67-74.
53. Wessner B, Strasser EM, Manhart N, Roth E. Supply of R-alpha-lipoic acid and glutamine to casein-fed mice influences the number of B lymphocytes and tissue glutathione levels during endotoxemia. Wien Klin Wochenschr 2006; 118: 100-107.
54. Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 1991; 101: 540-547.
55. Siems WG, Grune T, Werner A, Gerber G, Buntrock P, Schneider W. Protective influence of oxypurinol on the trinitrobenzene sulfonic acid (TNB) model of inflammatory bowel disease in rats. Cell Mol Biol 1992; 38: 189-199.
56. Varalakshmi P, Sandhya S, Malarkodi KP. Evaluation of the effect of lipoic acid administered along with gentamicin in rats rendered bacteremic. Mol Cell Biochem 2003; 248: 35-40.
57. Sandle GI. Pathogenesis of diarrhea in ulcerative colitis: new views on an old problem. J Clin Gastroenterol 2005; 39: S49-52.
58. Magro F, Fraga S, Ribeiro T, Soares-da-Silva P. Regional intestinal adaptations in Na+,K+-ATPase in experimental colitis and the contrasting effects of interferon-gamma. Acta Physiol Scand 2005; 183: 191-199.
59. Sasaki S, Hirata I, Maemura K, et al. Prostaglandin E2 inhibits lesion formation in dextran sodium sulphate-induced colitis in rats and reduces the level of mucosal inflammatory cytokines. Scand J Immunol 2000; 51:23-28.
60. Shiratova A, Aoki S, Takada H, et al. Oxygen derived free radicals generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 1989; 44: 163-171.
61. Sismonds NJ, Rampton DS. Inflammatory bowel disease: a radical view. Gut 1994; 34: 861-865.
62. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR. Early kidney TNF-expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 1999; 277: R922-R929.
63. Weiss SJ, Ward PA. Immune complex induced generation of oxygen metabolites by human neutrophils. J Immunol 1982; 129: 309-319.
64. Mervaala E, Finckenberg P, Lapatto R, et al. Lipoic acid supplementation prevents angiotensin II-induced renal injury. Kidney Int 2003; 64: 501-508.
65. Chaudhary P, Marracci GH, Bourdette DN. Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis. J Neuroimmunol 2006; 175: 87-96.
66. D'Odorico A, Bortolan S, Cardin R, et al. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 2001; 36: 1289-1294.
67. Martin AR, Villegas I, La Casa C, Alarcon de la Lastra C. The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats. Eur J Pharmacol 2003; 481: 281-291.
68. Kolgazi M, Jahovic N, Yüksel M, Ercan F, Alican I. Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats. J Gastroenterol Hepatol. 2007; 22:1859-1865.